SGA
Sector Gamma AS Portfolio holdings
AUM
$306M
This Quarter Return
+1.53%
1 Year Return
+4.68%
3 Year Return
+19.67%
5 Year Return
+46.47%
10 Year Return
+161.43%
AUM
$427M
AUM Growth
+$427M
(+1.1%)
Cap. Flow
-$3.29M
Cap. Flow
% of AUM
-0.77%
Top 10 Holdings %
Top 10 Hldgs %
56.98%
Holding
37
New
6
Increased
10
Reduced
14
Closed
4
Top Buys
| 1 |
Stryker
SYK
|
$17M |
| 2 |
Bristol-Myers Squibb
BMY
|
$10.6M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$10.4M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$8.36M |
| 5 |
Community Health Systems
CYH
|
$6.08M |
Top Sells
| 1 |
AbbVie
ABBV
|
$12.9M |
| 2 |
Agilent Technologies
A
|
$9.6M |
| 3 |
Eli Lilly
LLY
|
$9.47M |
| 4 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$6.71M |
| 5 |
Edwards Lifesciences
EW
|
$6.44M |
Sector Composition
| 1 | Healthcare | 85.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Integra LifeSciences
IART
$1.18B
| $5.67M | 1.33% |
114,191
+9,091
| +9% | +$451K |
|
|
CTRX
27
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $4.78M | 1.12% |
113,500
| – | – |
|
28
Cigna
CI
$80.3B
| $4.44M | 1.04% |
49,000
+9,000
| +23% | +$816K |
|
|
AGN
29
DELISTED
ALLERGAN INC
AGN
| $3.56M | 0.83% |
+20,000
| New | +$3.56M |
|
|
MDCO
30
DELISTED
Medicines Co
MDCO
| $3.47M | 0.81% |
155,450
-28,800
| -16% | -$643K |
|
|
AVNR
31
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $2.73M | 0.64% |
229,400
-440,000
| -66% | -$5.24M |
|
|
AUXL
32
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $2.57M | 0.6% |
85,920
-88,200
| -51% | -$2.63M |
|
|
SPPI
33
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $566K | 0.13% |
69,500
+19,500
| +39% | +$159K |
|
|
34
Agilent Technologies
A
$35.7B
| – | – |
-167,200
| Closed | -$9.6M |
|
|
35
AbbVie
ABBV
$372B
| – | – |
-228,500
| Closed | -$12.9M |
|
36
Dr. Reddy's Laboratories
RDY
$11.8B
| – | – |
-146,152
| Closed | -$6.31M |
|
37
UnitedHealth
UNH
$281B
| – | – |
-27,000
| Closed | -$2.21M |
|